CompaniesHorizon Pharmaceuticals

Horizon Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

150

By Phase

PHASE4: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
Today
Hover over trial bars to see details

Recent Trials

NCT06145360Collaborator
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
PHASE4Completed
150 participants
Started: Dec 1, 2023 · Completed: Mar 1, 2024